These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24151186)

  • 1. Advanced glycation end products in degenerative nucleus pulposus with diabetes.
    Tsai TT; Ho NY; Lin YT; Lai PL; Fu TS; Niu CC; Chen LH; Chen WJ; Pang JH
    J Orthop Res; 2014 Feb; 32(2):238-44. PubMed ID: 24151186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis, senescence, and autophagy in rat nucleus pulposus cells: Implications for diabetic intervertebral disc degeneration.
    Jiang L; Zhang X; Zheng X; Ru A; Ni X; Wu Y; Tian N; Huang Y; Xue E; Wang X; Xu H
    J Orthop Res; 2013 May; 31(5):692-702. PubMed ID: 23238821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation in receptor for advanced glycation end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro.
    Yoshida T; Park JS; Yokosuka K; Jimbo K; Yamada K; Sato K; Takeuchi M; Yamagishi S; Nagata K
    Spine (Phila Pa 1976); 2009 Jul; 34(15):1544-8. PubMed ID: 19564763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hyperglycemia on apoptosis of notochordal cells and intervertebral disc degeneration in diabetic rats.
    Won HY; Park JB; Park EY; Riew KD
    J Neurosurg Spine; 2009 Dec; 11(6):741-8. PubMed ID: 19951028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells.
    Song Y; Wang Y; Zhang Y; Geng W; Liu W; Gao Y; Li S; Wang K; Wu X; Kang L; Yang C
    J Cell Mol Med; 2017 Jul; 21(7):1373-1387. PubMed ID: 28224704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end-products downregulating intervertebral disc cell production of proteoglycans in vitro.
    Yokosuka K; Park JS; Jimbo K; Yamada K; Sato K; Tsuru M; Takeuchi M; Yamagishi S; Nagata K
    J Neurosurg Spine; 2006 Oct; 5(4):324-9. PubMed ID: 17048769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased periostin gene expression in degenerative intervertebral disc cells.
    Tsai TT; Lai PL; Liao JC; Fu TS; Niu CC; Chen LH; Lee MS; Chen WJ; Fang HC; Ho NY; Pang JH
    Spine J; 2013 Mar; 13(3):289-98. PubMed ID: 23453657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats.
    Umadevi S; Gopi V; Elangovan V
    Chem Biol Interact; 2014 Feb; 208():28-36. PubMed ID: 24309158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-1 of gingival fibroblasts influenced by advanced glycation end products (AGEs) and their association with receptor for AGEs and nuclear factor-κB in gingival connective tissue.
    Yu S; Li H; Ma Y; Fu Y
    J Periodontol; 2012 Jan; 83(1):119-26. PubMed ID: 21563948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRD4 inhibition regulates MAPK, NF-κB signals, and autophagy to suppress MMP-13 expression in diabetic intervertebral disc degeneration.
    Wang J; Hu J; Chen X; Huang C; Lin J; Shao Z; Gu M; Wu Y; Tian N; Gao W; Zhou Y; Wang X; Zhang X
    FASEB J; 2019 Oct; 33(10):11555-11566. PubMed ID: 31331201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
    Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
    Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
    Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
    Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired calcium homeostasis via advanced glycation end products promotes apoptosis through endoplasmic reticulum stress in human nucleus pulposus cells and exacerbates intervertebral disc degeneration in rats.
    Luo R; Song Y; Liao Z; Yin H; Zhan S; Wang K; Li S; Li G; Ma L; Lu S; Zhang Y; Yang C
    FEBS J; 2019 Nov; 286(21):4356-4373. PubMed ID: 31230413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts.
    Chen SC; Guh JY; Hwang CC; Chiou SJ; Lin TD; Ko YM; Huang JS; Yang YL; Chuang LY
    J Cell Biochem; 2010 Jan; 109(1):38-48. PubMed ID: 19885844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat.
    Kato T; Yamashita T; Sekiguchi A; Tsuneda T; Sagara K; Takamura M; Kaneko S; Aizawa T; Fu LT
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):415-20. PubMed ID: 18298515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.
    Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y
    J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
    Jeyabal PV; Kumar R; Gangula PR; Micci MA; Pasricha PJ
    Neurogastroenterol Motil; 2008 Mar; 20(3):253-61. PubMed ID: 17971026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.
    Candido R; Forbes JM; Thomas MC; Thallas V; Dean RG; Burns WC; Tikellis C; Ritchie RH; Twigg SM; Cooper ME; Burrell LM
    Circ Res; 2003 Apr; 92(7):785-92. PubMed ID: 12623881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
    Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
    J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.